Outlook Therapeutics, Inc. (OTLK): Price and Financial Metrics

Outlook Therapeutics, Inc. (OTLK): $5.28

0.05 (+0.96%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add OTLK to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#197 of 332

in industry

OTLK Price/Volume Stats

Current price $5.28 52-week high $12.85
Prev. close $5.23 52-week low $4.61
Day low $5.17 Volume 145,100
Day high $5.44 Avg. volume 344,029
50-day MA $5.64 Dividend yield N/A
200-day MA $7.40 Market Cap 124.90M

OTLK Stock Price Chart Interactive Chart >


Outlook Therapeutics, Inc. (OTLK) Company Bio


Outlook Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company engages in identifying, developing, manufacturing, and commercializing complex biosimilar therapeutics. Outlook Therapeutics focuses on monoclonal antibodies in the disease areas of immunology and oncology aspects. Outlook Therapeutics offers its services in the United States.


OTLK Latest News Stream


Event/Time News Detail
Loading, please wait...

OTLK Latest Social Stream


Loading social stream, please wait...

View Full OTLK Social Stream

OTLK Price Returns

1-mo -4.69%
3-mo -29.88%
6-mo -33.16%
1-year -41.41%
3-year -82.16%
5-year -75.09%
YTD -32.99%
2023 -63.52%
2022 -20.59%
2021 4.62%
2020 120.34%
2019 -85.25%

Continue Researching OTLK

Here are a few links from around the web to help you further your research on Outlook Therapeutics Inc's stock as an investment opportunity:

Outlook Therapeutics Inc (OTLK) Stock Price | Nasdaq
Outlook Therapeutics Inc (OTLK) Stock Quote, History and News - Yahoo Finance
Outlook Therapeutics Inc (OTLK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!